With the launch of the Agilent Dako Omnis family, Agilent transitions beyond a one-size-fits-all model to offer a tailored portfolio—empowering labs to select the configuration that best meets ...

Agilent to Acquire Dako for $2.2 Billion Acquisition is Next Step in Agilent’s Growing Role in Clinical Diagnostics Dako is one of the leading global providers of cancer diagnostics tools.

Listed Agilent Technologies Inc. has completed its acquisition of cancer diagnostics company Dako, buying the company from Sweden-based private equity shop EQT for $2.2 billion. The deal was first ...

Dako, an Agilent Technologies company, has signed an agreement to acquire the intellectual property rights behind connectivity software from California-based software development company System ...

Van Andel Research Institute and Dako, the Danish-based, worldwide supplier of cancer diagnostic tools today announce an agreement to license, manufacture and distribute cancer diagnostics ...

Dako, a world leader in tissue-based cancer diagnostics, has received approval from the US Food and Drug Administration (FDA) to market HER2 CISH pharmDx (TM) Kit in the United States.

Dako, an Agilent Technologies company specializing in providing cancer diagnostics, said today it has again expanded a three-year-old collaboration with Amgen focused on companion diagnostics.